Punctal Plug Device Market Report: Trends, Forecast and Competitive Analysis to 2035

Punctal Plug Device Market

The future of the global punctal plug device market looks promising with opportunities in the hospital and clinic markets. The global punctal plug device market is expected to reach an estimated $1.7 billion by 2035 from $1.1 billion in 2027 with a CAGR of 6.1% from 2027 to 2035. The major drivers for this market are the increasing prevalence of dry eye conditions, the rising demand for non-surgical eye treatments, and the growing awareness of punctal plug benefits.

• Lucintel forecasts that, within the type category, temporary punctal plugs is expected to witness higher growth over the forecast period due to more benefits such as flexibility and reversibility come with temporary punctal plugs.
• Within the application category, hospitals is expected to witness higher growth over the forecast period due to more patients with dry eye disease are being treated in hospital ophthalmology units.
• In terms of regions, APAC is expected to witness the highest growth over the forecast period due to the expansion in screen time, and thus, dry eye disease.

Emerging Trends in Punctal Plug Device Market

The punctal plug device market is moving away from basic products that help retain tears, and into the development of biocompatible devices that target specific ocular conditions and procedures. It is anticipated that by the years 2025 to 2027, the market would tandem with the availability and insertion of dry-eye diagnosis and related reimbursement. The market would also be influenced by the capacity of the ophthalmology workforce to perform the procedure. Based on the Lucintel report, positive volume and clinical evidence would strengthen the market outlook.

• Sustainability: In 2025, medical device manufacturers focused on reducing and eliminating the non-essential components of the device (i.e. packaging), and evaluated the use of bioabsorbable materials for use in ocular devices. Sustainability would be a critical component of a medical device in the next 3 to 5 years.
• Personalized Medicine: In 2025-2027, clinicians would utilize plugs based on the nature of the tear film deficiency and the duration and nature of the post-operative condition. Plugs of varying sizes and properties would be needed to achieve an optimal fit and to minimize the risk of extrusion.
• Office-based Care: For 2025 and beyond, chronic dry eye management trends toward office-based, procedure-extended, chronic care models. The majority of ophthalmology practice revenue is generated from the management of chronic disease. The ability of dry eye disease management practices to identify and implement more efficient pathways to chronic dry eye care will foster positive practice revenue trends through 2025.
• Smarter Materials: Improvements in biomaterials, drug delivery, and design will allow temporary devices to be developed with enhanced therapeutic value. The therapeutic window for many biomaterials will continue to improve, potentially allowing for better control over the duration of the device.
• Evidence-based Purchasing: A renewed emphasis on clinical evidence (especially for comparative effectiveness) by dry eye disease management practices will further segment the higher-end, premium devices from value-based devices. From 2025 to 2027, reimbursement decisions will also be influenced by this trend.

From a global perspective, the most favorable markets for the integration of temporary biomaterials for postoperative ocular surface management and office-based, chronic dry eye disease management will be emerging and high-growth markets through 2029.

Recent Developments in the Punctal Plug Device Market

The punctal plug market is moving toward individualized, drug-releasing, and canalicular plugs. 2025 will be spent improving the evidence around fit and insertion. Reimbursement will need to be determined prior to widespread clinical adoption. Commercialization is anticipated in 2026 and integration into clinical practice is anticipated in 2027. Lucy's expects competition to focus on developing products with a distinctive benefit in relation to dry-eye prevalence.

• The First Drug-releasing Plugs: In 2025, the U.S. Food and Drug Administration (FDA) is expected to approve an intracanalicular plug that is coated with a hydrogel that releases a drug. Plugs that incorporate drug-releasing technologies would enable the ophthalmic device manufacturer to charge a premium over traditional plugs.
• Regulatory Changes: The FDA's 510(k) pathway for review of medical devices and auxiliary products was anticipated to undergo changes in 2025 to enable greater competition and reduce product switching among ophthalmic device manufacturers.
• Joint Ventures: A major supplier of ophthalmic devices and a specialty pharmaceutical company formed a joint venture in 2025 to assess a drug that achieves therapy for 90 days. Joint ventures among competitor companies facilitate integration of drug and medical device products to expand the market beyond traditional products.
• Molding Capacity Expansion: A U.S. manufacturer increased molding capacity by 30% for hydrogel and silicone components in September 2025. With additional capacity, the manufacturer expects reduced reliance on imported complete devices. Shorter lead times and larger capacity will also help the manufacturer fulfill private label contracts.
• Clinical Evidence Funding: In the February 2026 funding cycle, a comparative effectiveness study to assess plug retention and the improvement of dry eye symptoms, funded by a group of government and private agencies, began enrolling. The study is expected to help determine reimbursement policies and assist in the development of clinical pathways for the integration of these devices into the practice of ophthalmology.

During the next five years, the market will expand beyond the current first generation devices to include innovative designs and drug delivery systems. Companies that equip their devices with clinically integrated delivery systems will have a competitive edge in this rapidly evolving market.

Strategic Growth Opportunities in the Punctal Plug Device Market

The increasing prevalence of dry eyes, along with the adoption of office-based eye care by optometrists, has caused a shift in the eye care market. Combine this with the increasing global population and a shortage of eyecare drugs, and it has created a market demand for eye care products and services. According to Lucintel, the market will shift in 2024 to 2026, to refine the materials used in punctal plugs and the types of eye care services offered.

• Premium Biocompatible Plugs: Manufacturers can charge higher prices for biocompatible plugs and expect reimbursement from insurance companies. Inflammation and migration of plugs leads to extrusion. A 2025 clinical report estimated that 300 million people are affected by dry eyes. Better design and comfort can affect how often plugs are replaced, and which ophthalmologists are preferred. From 2025 to 2030, market trends will depend on specialized care.
• Post-Surgical Care: Manufacturers can target cataract and refractive surgeries and integrate plugs into their service offerings. Cataract procedures are expected to increase to over 30 million by 2026. Plugs can help improve post-op care and provide eye care service manufacturers an opportunity to differentiate their products and services.
• Emerging Market Expansion: Currently, EyeLook focuses on developed markets like North America and Europe. There are opportunities to expand into less developed markets because local distributors are usually willing to carry smaller packages of EyeLook products. Also, the costs to manufacture and distribute EyeLook products are expected to be lower in new markets. EyeLook's products may be more accepted and widely available if the local population has adequate access to eye care and EyeLook employs appropriate pricing strategies. For example, EyeLook may be successful in India where the ophthalmology market is rapidly expanding and serving over 1.4 billion people.
• Drug Device Combination: EyeLook has an opportunity to develop drug-device combinations. If EyeLook incorporates an anti-inflammatory or lubricating drug into a plug, then that product could have a stronger economic outcome than existing products. Furthermore, EyeLook may have an opportunity to collaborate with other pharmaceutical companies in developing ophthalmic products. Controlled release products may also appeal to ophthalmologists if the products reduce the number of times eye drops must be administered.
• Digital Fitness Services: Recent advances in information technology may allow EyeLook to develop fitting and eye care services without a physical presence. Products which incorporate telemedicine may be favourable received in the marketplace because they may reduce the number of office visits and provide more convenient eye care. EyeLook should develop such products.

Research and development should be focused primarily on innovations which integrate EyeLook products with drug delivery devices and on developing other products which provide clinical improvements over existing products. If EyeLook integrates drug delivery devices with surgical devices used to open and close the nasolacrimal ducts, then those products would probably be reimbursed. However, EyeLook may find it challenging to receive reimbursement for other products. Favorable market conditions are likely to exist for EyeLook's products which reduce the number of eye care visits and provide clinical benefits to the patient. EyeLook should concentrate its resources on developing such products.

Punctal Plug Device Market Drivers and Challenges

Punctal plug devices treat dry eyes by occluding the puncta of the eye to prevent tears from draining. The global market for punctal plug devices is expected to grow with the increasing elderly population, improvement in available technology, more liberalized medical device regulations and greater healthcare spending. Concerns for clinician training and experience, potential side effects and anxiety about the long-term effects of the devices may limit the adoption of punctal plugs. According to Lucintel, the punctal plug market will grow in the next few years because of new product innovations and improvements in the awareness and training of ophthalmologists.

The factors responsible for driving this market include:

• Rising Dry Eye Prevalence: Continuously increasing global cases of dry eye. In 2025, an estimated over 300 million people were reported to have dry eye syndrome. As the average age of the global population increases and more people use digital devices, the prevalence of dry eyes is also expected to increase. Improvements in medical diagnostic equipment and the introduction of new dry eye symptom standards may result in an increase in the number of people with dry eyes. This may stimulate the ophthalmology market and increase the adoption of punctal plugs.
• Technological Innovation: A number of technology advances are improving the comfort and adoption of punctal plugs. Extended-release and drug-delivery plugs are under development. More anatomic plug designs are expected in the marketplace by 2025. Manufacturing advances may improve plug designs to reduce extrusion by 2025. New delivery systems may further improve plug acceptance.
• Growing Geriatric Population: The worldwide increase of the 65+ age group creates a larger patient base at increased risk of dry eye due to inflammatory conditions. This population is at increased risk of post-surgical dry eye. Global demand for more effective office-based therapies for dry eye and other ophthalmic conditions is increasing. Demographic trends support a decline in the use of conventional, repetitive dry eye therapy.
• Expansion of Ophthalmic Procedures: Increased global surgical volumes for refractive and cataract surgery will stimulate demand for plugs to prevent corneal and conjunctival drying in the perioperative period. New obstacles to the stable tear film created by ophthalmic procedures will create new and sustained demand for temporary punctal plugs in the coming years.
• Minimally Invasive Treatment Preference: Patient and healthcare worker preferences are shifting towards less-invasive treatments that require little to no equipment, have a short procedure time and recovery time. The insertion of punctal plugs to treat PTSD became available in 2025. Compared to traditional treatments for PTSD, the insertion of punctal plugs is convenient. Other invasive treatments will be compared to traditional treatments of PTSD, and punctal plugs will be combined with traditional treatments.

The challenges facing this market include:

• Cost and Reimbursement: Punctal plugs are not covered by many health insurance plans. Patients have to pay out-of-pocket to purchase the plugs and have them inserted. Many health insurance plans will not cover the plugs unless it is deemed medically necessary. Costs, and limiting insurance plans, will adversely impact the plugs and other invasive devices in the market.
• Variability of Retention: Some patients experience migration or irritation from the plugs. A variety of adverse events can occur from the plugs including obstruction of the tear ducts. In 2025, many clinicians used a two-step process to insert the plugs to maintain patient satisfaction and assess if the plugs were obstructing the tear ducts. It is anticipated that by 2030, research will be completed on methods to improve the design of the plugs to better maintain patient satisfaction.
• Alternative Therapies: Competitors to punctal occlusion include artificial tears, other anti-inflammatory medications, thermal and light treatments, and recent additions such as autologous serum and lifestyle modifications. There is already a range of eye lubricants and anti-inflammatory medications on the market. The key differences with punctal occlusion will be the discreet and long-lasting nature of the treatment, perhaps spanning days to weeks, and the potential for a significant improvement in symptoms as opposed to the incremental improvements associated with lubricating eye-drops. In the short to medium term, evidence and professional judgement will determine the extent of improvement dry eye patients can expect from the use of punctal plugs.

The punctal occlusion device has the potential to offer dry eye patients the respite from their symptoms that they need, and deserves to have. Aging is known to increase incidences of dry eye. Other market drivers include increased ophthalmic surgeries and an increased demand for less invasive ophthalmic procedures. There is also the potential for improvements in design to enhance comfort and usability. Like all medical devices, complications and moderate-to-unreliable improvement in symptoms will challenge the market potential. The main competitors will be pharmaceutical and medical device companies.

List of Punctal Plug Device Market Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies punctal plug device market companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the punctal plug device market companies profiled in this report include-

• Ocular Therapeutix
• Corza Medical
• FCI Ophthalmics
• BVI Medical
• Innovia Medical
• Oasis Medical
• Lacrivera

Punctal Plug Device Market by Segment

The study includes a forecast for the global punctal plug device market by type, application, and region.

Punctal Plug Device Market by Type [Value ($B) from 2019 to 2035]:

• Temporary Punctal Plugs
• Permanent Punctal Plugs

Punctal Plug Device Market by Application [Value ($B) from 2019 to 2035]:

• Hospitals
• Clinics

Punctal Plug Device Market by Region [Value ($B) from 2019 to 2035]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Punctal Plug Device Market

The punctal plug device market is anticipated to expand due to investment in ophthalmology, and efforts by companies to develop other methods for the treatment of dry eye. It is expected that between 2025 and 2027, the market will be dominated by the need to strategically locate the production of devices and distribute them in accordance with the laws of various countries. According to a recent report by Lucintel, these will be the prevailing trends in the market.

• United States: It is expected that the regulation and reimbursement of lacrimal procedures will continue to encourage the performance of these procedures in the doctor's office. In 2025, plugs for punctal occlusion were required to be registered with the FDA, and manufacturers were required to list the devices. BVI and OASIS were the main suppliers and continued to sell their plugs in the market. It is expected that in the next 3 to 5 years, regulators will simplify the process of plug device approval and therefore reduce the time it takes for new plug designs to enter the market.
• China: China's NMPA kept domestic registration requirements for ophthalmic devices in 2025. Local companies, however, actively participated in local hospital procurement and import substitution. As of 2024, the Chinese Medical Doctor Association reported over 40,000 ophthalmologists. As of December 2025, local registrations of ophthalmic devices was of growing importance for market access.
• Germany: In 2025, the European Commission initiated a new phase of the implementation of EUDAMED. Simultaneously, in the MDR context, the clinical and post-market requirements for ophthalmic devices in Germany did not change. Punctal plugs remain subject to higher requirements throughout the EU.
• India: The Indian government continued to promote local manufacture of medical devices, including ophthalmic devices. As part of the same initiative, the Indian government 2024-25 budget allocated INR 32000 crore for local manufacture of medical devices. Local production of punctal plugs is anticipated.
• Japan: In 2025, the Japanese MHLW announced reimbursement changes and the PMDA continued to review clinical data for market access of ophthalmic devices. New market entrants should undertake clinical studies to address specific ophthalmic conditions.

Features of the Global Punctal Plug Device Market

• Market Size Estimates: punctal plug device market size estimation in terms of value ($B).
• Trend and Forecast Analysis: Market trends (2019 to 2026) and forecast (2027 to 2035) by various segments and regions.
• Segmentation Analysis: punctal plug device market size by type, application, and region in terms of value ($B).
• Regional Analysis: punctal plug device market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
• Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the punctal plug device market.
• Strategic Analysis: This includes M&A, new product development, and competitive landscape of the punctal plug device market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the punctal plug device market by type (temporary punctal plugs and permanent punctal plugs), application (hospitals and clinics), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 8 years and what has its impact been on the industry?